Member Info for Yorkshirepragma

RK,
Many thanks thanks for directing towards this. AS balanced and thoughtful as ever. Shame on delay re cancer trails, but that’s that.
Comment on Scale ( best word for it perhaps) of Covid testing is Thanks indicative of what’s to come. Adeptrix testing might be better than current too...superb.
Hold onto all.

RNS ...testing...revenues transformational for the company....That’ll do...

Including a test...immediate

UK government...24 turnaround is VIP ...a’ la Avacta/ Cytiva !

With 5m buys v 2m sells at 1400 ?

Buys> sells .......

NYSE open shortly..

Buysx2 sold...!

That TIMING apologies

This is now AVACTAS CLIENTS prerogative , and to wing will be driven by them. Stateside .

RK,
Your comments on future areas for ‘ethical’ or ‘worthwhile for all ‘ investment strike a chord. Perhaps there a newer “belief’ in seeking to do the right thing coming through? Investment for everyone’s benifit(S).
Here’s to hope ( and faith)

RNS Would be on USA link time more often for Partner reasons.

https://pages.questexnetwork.com/Precision-Registration-05192020.html?source=toasterad

Noted.., you pays your money &....
GLA

That puts you down X000 and future potential Loss of X x 5,£000.... good luck?

https://www.fiercebiotech.com/topic/mergers-and-acquisitions
The inevitable....

Well said! Here’s to progress.

Buys>1m sells

https://www.fiercebiotech.com/biotech/merck-inks-themis-buyout-to-join-covid-19-vaccine-race

Am sure MMs shortly to be produced updates will support matters, but it’s interesting that we have a good price shift on prospects .
Surveying recent Biotech ‘new starts’ buyouts in last few years indicates a further uplift in value on acquisition, which may be on the cards here I suspect.
Be interesting to see what Myles view is visa v. Initial paper. It’s certainly as income appears going to be $ 3/5 bn prob?
Let’s see..
GLA